Cytek Biosciences, Inc.CTKBNASDAQ
LOADING
|||
Price to Sales: Discounted Valuation
Trending lower, below historical average, structural decline.
Left:
||||
Price-to-sales ratio
Latest
4.23
↓ 76% below average
Average (5y)
17.67
Historical baseline
Range
High:43.10
Low:4.23
CAGR
-37.1%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | 4.23 | -33.8% |
| 2023 | 6.39 | -23.7% |
| 2022 | 8.37 | -50.9% |
| 2021 | 17.06 | -36.5% |
| 2020 | 26.87 | -37.7% |
| 2019 | 43.10 | - |